Revelation Biosciences, Inc.
REVB
$0.90
-$0.04-4.70%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.71M | 5.17M | 3.70M | 6.50M | 6.54M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 123.90K | 186.00K | 223.30K | 66.70K | 117.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 12.83M | 5.36M | 3.93M | 6.57M | 6.66M |
|
|
|||||
| Total Current Assets | 12.83M | 5.36M | 3.93M | 6.57M | 6.66M |
| Net Property, Plant & Equipment | 23.90K | 35.20K | 42.40K | 56.30K | 81.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 12.86M | 5.40M | 3.97M | 6.62M | 6.74M |
|
|
|||||
| Total Accounts Payable | 1.04M | 828.90K | 625.10K | 783.60K | 3.13M |
| Total Accrued Expenses | 819.40K | 739.60K | 463.60K | 1.13M | 934.40K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 200.00 | 800.00 | 800.00 | 2.20K | 4.80K |
| Total Other Current Liabilities | 200.00 | 800.00 | 800.00 | 2.20K | 4.80K |
| Total Current Liabilities | 1.85M | 1.57M | 1.09M | 1.91M | 4.07M |
|
|
|||||
| Total Current Liabilities | 1.85M | 1.57M | 1.09M | 1.91M | 4.07M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.85M | 1.57M | 1.09M | 1.91M | 4.07M |
|
|
|||||
| Common Stock & APIC | 57.91M | 48.83M | 45.44M | 45.21M | 41.45M |
| Retained Earnings | -46.91M | -45.00M | -42.56M | -40.51M | -38.78M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 11.00M | 3.83M | 2.88M | 4.71M | 2.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.00M | 3.83M | 2.88M | 4.71M | 2.67M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.00M | 3.83M | 2.88M | 4.71M | 2.67M |
|
|
|||||